David J. Warren

5.9k total citations
137 papers, 3.4k citations indexed

About

David J. Warren is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, David J. Warren has authored 137 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 33 papers in Molecular Biology and 29 papers in Genetics. Recurrent topics in David J. Warren's work include Monoclonal and Polyclonal Antibodies Research (19 papers), Inflammatory Bowel Disease (17 papers) and Microscopic Colitis (16 papers). David J. Warren is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (19 papers), Inflammatory Bowel Disease (17 papers) and Microscopic Colitis (16 papers). David J. Warren collaborates with scholars based in Norway, United States and United Kingdom. David J. Warren's co-authors include Colin J. Sanderson, Malcolm Strath, M A Moore, Nils Bolstad, Kjell Nustad, Michelle Moore, Anne O’Garra, G. G. B. Klaus, J Ledingham and Lars Slørdal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Experimental Medicine.

In The Last Decade

David J. Warren

130 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Warren Norway	29	1.3k	712	557	448	397	137	3.4k
Philippe Rieu France	30	1.3k 1.0×	1.2k 1.7×	261 0.5×	281 0.6×	268 0.7×	104	4.5k
José Francisco Muñóz-Valle Mexico	32	1.3k 1.0×	784 1.1×	360 0.6×	516 1.2×	378 1.0×	286	3.9k
Marvin R. Garovoy United States	37	2.6k 2.1×	789 1.1×	304 0.5×	230 0.5×	467 1.2×	141	5.0k
Gilberto Filaci Italy	34	2.0k 1.6×	843 1.2×	258 0.5×	218 0.5×	632 1.6×	121	4.1k
Alan D. Levine United States	38	2.0k 1.6×	1.2k 1.6×	338 0.6×	628 1.4×	550 1.4×	113	4.3k
Monique Vogel Switzerland	35	1.1k 0.9×	830 1.2×	595 1.1×	162 0.4×	151 0.4×	142	3.6k
Xavier Culleré United States	25	1.8k 1.4×	1.3k 1.8×	291 0.5×	320 0.7×	322 0.8×	38	3.9k
Αthanasia Mouzaki Greece	30	932 0.7×	659 0.9×	230 0.4×	202 0.5×	338 0.9×	128	2.8k
Robert A. Swerlick United States	36	1.6k 1.3×	1.9k 2.7×	492 0.9×	276 0.6×	814 2.1×	136	6.0k
George Füst Hungary	40	2.2k 1.8×	1.3k 1.8×	273 0.5×	500 1.1×	225 0.6×	232	5.5k

Countries citing papers authored by David J. Warren

Since Specialization

Citations

This map shows the geographic impact of David J. Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Warren more than expected).

Fields of papers citing papers by David J. Warren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Warren. The network helps show where David J. Warren may publish in the future.

Co-authorship network of co-authors of David J. Warren

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Warren. A scholar is included among the top collaborators of David J. Warren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Warren. David J. Warren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klaasen, Rolf Anton, David J. Warren, Nils Bolstad, et al.. (2025). Serological screening for coeliac disease in an adult general population: the HUNT study. Gut. 74(6). 918–925. 1 indexed citations

Gehin, Johanna Elin, Rolf Anton Klaasen, Eirik Klami Kristianslund, et al.. (2024). Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial. RMD Open. 10(4). e004888–e004888.

Høivik, Marte Lie, David J. Warren, Nils Bolstad, et al.. (2023). Switching from intravenous to subcutaneous vedolizumab maintenance treatment in patients with inflammatory bowel disease followed by therapeutic drug monitoring. Scandinavian Journal of Gastroenterology. 58(8). 863–873. 18 indexed citations

Jørgensen, Kristin Kaasen, Marte Lie Høivik, Adity Chopra, et al.. (2023). Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type. Scandinavian Journal of Gastroenterology. 58(8). 874–882. 2 indexed citations

Viken, Marte K., Grethe‐Elisabeth Stenvik, Rolf Anton Klaasen, et al.. (2023). HLA‐DQ2 is associated with anti‐drug antibody formation to infliximab in patients with immune‐mediated inflammatory diseases. Journal of Internal Medicine. 293(5). 648–655. 7 indexed citations

Syversen, Silje Watterdal, Anne Therese Tveter, Joe Sexton, et al.. (2022). Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy. RMD Open. 8(2). e002417–e002417. 10 indexed citations

Goll, Guro Løvik, Kristin Kaasen Jørgensen, Joseph Sexton, et al.. (2022). Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. Journal of Internal Medicine. 292(3). 477–491. 26 indexed citations

Gehin, Johanna Elin, Rolf Anton Klaasen, David J. Warren, et al.. (2021). Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort. Rheumatology International. 41(9). 1657–1665. 13 indexed citations

Høivik, Marte Lie, Milada Cvancarova, David J. Warren, et al.. (2018). Switching from originator to biosimilar infliximab – real world data of a prospective 18 months follow-up of a single-centre IBD population. Scandinavian Journal of Gastroenterology. 53(6). 692–699. 39 indexed citations

10.

Warren, David J., et al.. (2017). Functional analysis of microRNA pathway genes in the somatic gonad and germ cells during ovulation in C. elegans. Developmental Biology. 426(1). 115–125. 16 indexed citations

11.

Laxmikanthan, Gurunathan, Chen Xu, Axel F. Brilot, et al.. (2016). Structure of a Holliday junction complex reveals mechanisms governing a highly regulated DNA transaction. eLife. 5. 15 indexed citations

12.

Warren, David J., Gurunathan Laxmikanthan, & Arthur Landy. (2008). A chimeric Cre recombinase with regulated directionality. Proceedings of the National Academy of Sciences. 105(47). 18278–18283. 19 indexed citations

13.

Warren, David J., et al.. (2008). Automated Time-Resolved Immunofluorometric Assay for Progastrin-Releasing Peptide. Clinical Chemistry. 54(5). 919–922. 19 indexed citations

14.

Laver, J, Miguel R. Abboud, Cristina Gasparetto, et al.. (1990). High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. The Journal of Pediatrics. 116(4). 627–632. 56 indexed citations

15.

Slørdal, Lars, et al.. (1989). Radioprotection by murine and human tumor‐necrosis factor: Dose‐dependent effects on hematopoiesis in the mouse. European Journal Of Haematology. 43(5). 428–434. 29 indexed citations

16.

Lu, Ling, Edward F. Srour, David J. Warren, et al.. (1988). Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor- alpha . Synergism with recombinant human IFN-gamma.. The Journal of Immunology. 141(1). 201–207. 29 indexed citations

17.

Warren, David J. & Michelle Moore. (1988). Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells.. The Journal of Immunology. 140(1). 94–99. 113 indexed citations

18.

Naik, Ramesh, Christopher J. Mathias, John L. Reid, & David J. Warren. (1985). Effect of Haemodialysis on the Control of the Circulation in Patients with Chronic Renal Failure. American Journal of Nephrology. 5(2). 96–102. 6 indexed citations

19.

Sanderson, Colin J., David J. Warren, & Malcolm Strath. (1985). Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures.. The Journal of Experimental Medicine. 162(1). 60–74. 244 indexed citations

20.

Warren, David J., C. P. Swainson, & N. Wright. (1974). Deterioration in Renal Function after Beta-blockade in Patients with Chronic Renal Failure and Hypertension. BMJ. 2(5912). 193–194. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact